Education
About Us
Working with TipRanks
Follow Us
Pediatrix Medical Group (MD)
NYSE:MD
Total Valuation
Pediatrix Medical Group has a market cap or net worth of $1.05B. The enterprise value is $1.44B.
Market Cap$1.05B
Enterprise Value$1.44B
Share Statistics
Pediatrix Medical Group has 85,816,880 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding85,816,880
Owned by Insiders1.48%
Owned by Institutions0.39%
Financial Efficiency
Pediatrix Medical Group’s return on equity (ROE) is -0.14 and return on invested capital (ROIC) is -3.83%.
Return on Equity (ROE)-0.14
Return on Assets (ROA)-0.05
Return on Invested Capital (ROIC)-3.83%
Return on Capital Employed (ROCE)-0.04
Revenue Per Employee488.57K
Profits Per Employee-24.05K
Employee Count4,120
Asset Turnover0.94
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Pediatrix Medical Group is -10.55. Pediatrix Medical Group’s PEG ratio is -0.15.
PE Ratio-10.55
PS Ratio0.61
PB Ratio1.43
Price to Fair Value1.43
Price to FCF5.92
Price to Operating Cash Flow5.29
PEG Ratio-0.15
Income Statement
In the last 12 months, Pediatrix Medical Group had revenue of 2.01B and earned -103.61M in profits. Earnings per share was -1.24.
Revenue2.01B
Gross Profit2.01B
Operating Income-68.71M
Pretax Income-101.34M
Net Income-103.61M
EBITDA-28.37M
Earnings Per Share (EPS)-1.24
Cash Flow
In the last 12 months, operating cash flow was 215.46M and capital expenditures -22.02M, giving a free cash flow of 193.43M billion.
Operating Cash Flow215.46M
Free Cash Flow193.43M
Free Cash Flow per Share2.25
Dividends & Yields
Pediatrix Medical Group pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.08
52-Week Price Change35.81%
50-Day Moving Average14.10
200-Day Moving Average12.68
Relative Strength Index (RSI)36.09
Average Volume (3m)677.66K
Important Dates
Pediatrix Medical Group upcoming earnings date is May 6, 2025, TBA Not Confirmed.
Last Earnings DateFeb 20, 2025
Next Earnings DateMay 6, 2025
Ex-Dividend Date―
Financial Position
Pediatrix Medical Group as a current ratio of 1.47, with Debt / Equity ratio of 86.58%
Current Ratio1.47
Quick Ratio1.47
Debt to Market Cap0.61
Net Debt to EBITDA-15.24
Interest Coverage Ratio-1.69
Taxes
In the past 12 months, Pediatrix Medical Group has paid -2.27M in taxes.
Income Tax-2.27M
Effective Tax Rate0.02
Enterprise Valuation
Pediatrix Medical Group EV to EBITDA ratio is -53.77, with an EV/FCF ratio of 8.27.
EV to Sales0.76
EV to EBITDA-53.77
EV to Free Cash Flow8.27
EV to Operating Cash Flow7.39
Balance Sheet
Pediatrix Medical Group has $348.51M in cash and marketable securities with $129.38M in debt, giving a net cash position of $313.81M billion.
Cash & Marketable Securities$348.51M
Total Debt$129.38M
Net Cash$313.81M
Net Cash Per Share$3.66
Tangible Book Value Per Share-$5.87
Margins
Gross margin is 21.62%, with operating margin of -3.41%, and net profit margin of -5.15%.
Gross Margin21.62%
Operating Margin-3.41%
Pretax Margin-5.03%
Net Profit Margin-5.15%
EBITDA Margin-1.41%
EBIT Margin-3.01%
Analyst Forecast
The average price target for Pediatrix Medical Group is $18.08, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$18.08
Price Target Upside47.59% Upside
Analyst ConsensusModerate Buy
Analyst Count6
Revenue Growth Forecast0.92%
EPS Growth Forecast-65.03%